Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial.
暂无分享，去创建一个
T. Choueiri | M. Atkins | M. Fishman | T. Olencki | E. Plimack | I. Puzanov | D. Cho | U. Vaishampayan | D. McDermott | S. George | J. Tarazi | B. Rosbrook | M. Lechuga | Kathrine C. Fernandez